Technical Analysis for ABMD - ABIOMED, Inc.

Grade Last Price % Change $ Change
grade C $113.27 -0.66% -0.75
ABMD closed down 0.66 percent on Wednesday, January 18, 2017, on 54 percent of normal volume. It was able to find support at its 50 day moving average.

Earnings due: 2017-01-26

Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Flat Down
See historical ABMD trend table...

Date Alert Name Type % Chg
Jan 18 50 DMA Support Bullish 0.00%
Jan 18 Bollinger Band Squeeze Range Contraction 0.00%
Jan 13 Crossed Above 50 DMA Bullish -2.07%
Jan 12 Bullish Engulfing Bullish 0.77%
Jan 12 Upside 200 DMA Break Bullish 0.77%
Jan 12 50 DMA Resistance Bearish 0.77%
Jan 11 Downside 200 DMA Break Bearish 1.80%
Jan 11 Fell Below 50 DMA Bearish 1.80%
Jan 10 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.92%
Jan 10 Doji - Bullish? Reversal 0.92%

Older signals for ABMD ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.

ABIOMED, Inc. provides medical devices in circulatory support and continuum of care in heart recovery to acute heart failure patients. Its products consist of Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; Impella CP, a micro heart pump; and Impella 5.0 catheter and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite. The company also manufactures and sells the Impella RP, a percutaneous catheter-based axial flow pump; and AB5000 circulatory support system and the BVS 5000 biventricular support system for temporary support of acute heart failure patients in profound shock, including patients suffering from cardiogenic shock after a heart attack, post-cardiotomy cardiogenic shock, or myocarditis. In addition, it offers Symphony, a synchronized minimally invasive implantable cardiac assist device designed to treat chronic patients with moderate heart failure by improving patient hemodynamics; and AbioCor implantable replacement heart. The company sells its products through direct sales and clinical support personnel in the United States, Canada, Germany, France, the United Kingdom, and internationally. ABIOMED, Inc. was founded in 1981 and is headquartered in Danvers, Massachusetts.
Is ABMD a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 0 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 132.95
52 Week Low 67.81
Average Volume 437,926
200-Day Moving Average 111.97
50-Day Moving Average 113.03
20-Day Moving Average 113.72
10-Day Moving Average 114.2
Average True Range 2.95
ADX 16.62
+DI 18.4
-DI: 22.49
Chandelier Exit (Long, 3 ATRs) 111.94
Chandelier Exit (Short, 3 ATRs) 118.68
Upper Bollinger Band 117.0
Lower Bollinger Band 110.44
Percent B (%b) 0.43
Bandwidth 0.057686